Represented a global investment institution in a cross-border DOJ investigation.
Represented a publicly traded e-commerce company in an SEC investigation concerning allegations of accounting fraud, insider trading and undisclosed related-party transactions made in a high-profile short seller report.
Advised a pharmaceutical, medical device and diagnostic company regarding an internal investigation into potential violations of the Foreign Corrupt Practices Act and the False Claims Act.